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Abstract
Background: Bladder pain of unknown etiology has been associated with co-morbid conditions and functional
abnormalities in neighboring pelvic organs. Mechanisms underlying pain co-morbidities include cross-sensitization,
which occurs predominantly via convergent neural pathways connecting distinct pelvic organs. Our previous results
showed that colonic inflammation caused detrusor instability via activation of transient receptor potential vanilloid
1 (TRPV1) signaling pathways, therefore, we aimed to determine whether neurogenic bladder dysfunction can
develop in the absence of TRPV1 receptors.
Methods: Adult male C57BL/6 wild-type (WT) and TRPV1−/− (knockout) mice were used in this study. Colonic
inflammation was induced by intracolonic trinitrobenzene sulfonic acid (TNBS). The effects of transient colitis on
abdominal sensitivity and function of the urinary bladder were evaluated by cystometry, contractility and relaxation
of detrusor smooth muscle (DSM) in vitro to various stimuli, gene and protein expression of voltage-gated sodium
channels in bladder sensory neurons, and pelvic responses to mechanical stimulation.
Results: Knockout of TRPV1 gene did not eliminate the development of cross-sensitization between the colon and
urinary bladder. However, TRPV1−/− mice had prolonged intermicturition interval and increased number of
non-voiding contractions at baseline followed by reduced urodynamic responses during active colitis. Contractility
of DSM was up-regulated in response to KCl in TRPV1−/− mice with inflamed colon. Application of Rho-kinase
inhibitor caused relaxation of DSM in WT but not in TRPV1−/− mice during colonic inflammation. TRPV1−/− mice
demonstrated blunted effects of TNBS-induced colitis on expression and function of voltage-gated sodium
channels in bladder sensory neurons, and delayed development of abdominal hypersensitivity upon colon-bladder
cross-talk in genetically modified animals.
Conclusions: The lack of TRPV1 receptors does not eliminate the development of cross-sensitization in the pelvis.
However, the function of the urinary bladder significantly differs between WT and TRPV−/− mice especially upon
development of colon-bladder cross-sensitization induced by transient colitis. Our results suggest that TRPV1
pathways may participate in the development of chronic pelvic pain co-morbidities in humans.
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Background
Chronic pelvic pain (CPP) is a common symptom of many
urologic and gastrointestinal disorders, including interstitial
cystitis/bladder pain syndrome (IC/BPS), irritable bowel
syndrome (IBS), and non-bacterial prostatitis/chronic pelvic
pain syndrome. A high level of co-morbidities among CPP
disorders is well documented in the clinical setting [1-3].
The etiology of IC/BPS is often complicated by visceral
hypersensitivity arising from the gastrointestinal (GI) tract
[1,4]. Similarly, a significant number of patients with IBS
complain of urinary symptoms, including nocturia [5],
frequency and urgency of micturition [2] and incomplete
bladder emptying [6]. Viscero-visceral reflexes between the
lower GI and urinary tracts are controlled by both
autonomic and central nervous systems (CNS), suggesting
the dominant role of neural pathways in pelvic organ
co-morbidities.
The latest research efforts aimed at understanding the
mechanisms underlying complex CPP disorders provided
evidence that cross-sensitization in afferent pathways may
initiate the development of neurogenic inflammation in the
pelvis and functional chronic pelvic pain [7,8]. Cross-
sensitization among pelvic organs implies the transmission
of noxious stimuli from a diseased pelvic organ to an adja-
cent normal structure resulting in the occurrence of func-
tional changes in the latter [9]. A pathological condition
developed in one of the pelvic organs may cause initial
sensitization of peripheral afferent fibers and sensory neu-
rons. These primary changes then lead to amplification of
nociceptive signaling in the CNS followed by descending
modulatory input from the CNS to the periphery [8-10].
The use of animal models provides insight into investi-
gation of functional changes in nerve fibers and neurons
as research of these in humans has certain challenges. Of
major interest for the studies of functional co-morbidities
are animal models in which an initial acute stimulus
(inflammation, infection, noxious distension, trauma, and
so on) is transient but powerful enough to cause long-
lasting abdominal hypersensitivity and hyperexcitability of
visceral afferents [11-13]. Several independent investiga-
tions established that transient inflammation of the distal
colon in animal models induces the occurrence of neuro-
genic cystitis due to cross-sensitization in neural pathways
[14-19]. After recovery from transient colitis, neither the
colon nor the urinary bladder demonstrated detectable
histological/biochemical changes suggestive of active in-
flammation. However, the bladder develops many signs of
neurogenic dysfunction evaluated by cystometry [14],
hyperexcitability of bladder sensory [13,16] and spinal [20]
neurons, release of pro-inflammatory neuropeptides in the
bladder [21], and altered detrusor contractility [14,22].
Recent functional and molecular studies from our labora-
tory identified the changes in a number of nociception-
related genes and an increased release of pro-inflammatory
neuropeptides in the urinary bladder following transient
inflammation of the distal gut [16,21]. We also established
that these changes are associated with activation of
intracolonic transient receptor potential vanilloid 1
(TRPV1) receptors [21]. TRPV1 is a non-specific cation
channel activated by heat, protons, and vanilloids [23]. It is
expressed in many visceral organs including the colon and
urinary bladder [24,25] with the highest level of expression
in primary sensory neurons innervating the visceral and
somatic structures [23]. A growing body of evidence has
led to the emergence of TRPV1 as a key player in sensory
transduction. The role of TRPV1 in somatic pain has been
extensively studied during the last decade, however, much
less is known about the involvement of TRPV1 in viscero-
visceral hyperalgesia and chronic visceral pain. To address
the role of TRPV1 in nociceptive signal transmission from
the inflamed colon to the urinary bladder and development
of neurogenic bladder dysfunction, we evaluated the effects
of TRPV1 gene knockout on the function of the urinary
bladder, detrusor contractility and associated signaling
in vivo and in vitro in a model of colon-bladder
cross-sensitization using TRPV1 knockout mice.
Materials and methods
Animals and experimental groups
Adult male C57BL/6 wild-type (WT) and TRPV1 gene-
deleted (TRPV1−/−, KO) mice (10 to 12 wks, 20 to 25 g,
Jackson Laboratories, Bar Harbor, ME, USA; N = 56) were
used in this study. Animals were housed in a regulated
environment, with free access to food and water and main-
tained on a 12:12-h light/dark cycle. There were no overt
differences in feeding behavior, litter size, growth rate and
body weight between the WT and TRPV1−/− mice.
Animals were divided into four experimental groups: 1)
WT control group; 2) WT group with colonic inflamma-
tion; 3) TRPV1−/− control group; and 4) TRPV1−/− mice
with colonic inflammation. Animals from each group were
used for in vivo and in vitro experiments at 3 to 5 days after
intracolonic treatments. All protocols were approved by the
University of Pennsylvania Institutional Animal Care
and Use Committee and adhered to the guidelines for
experimental pain in animals published by the International
Association for the Study of Pain.
Animal model of colon-bladder cross-sensitization
induced by colonic inflammation
Transient colonic inflammation was induced by a single
administration of 2,4,6-trinitrobenzene sulfonic acid
(TNBS, 60 mg/kg, in 25% C2H5OH), a chemical irritant
that causes inflammation in the intestine. The TNBS solu-
tion was prepared fresh before the instillation procedure.
Animals were anesthetized with isoflurane (VEDCO Inc.,
St. Joseph, MO, USA) and intracolonic treatments were
performed via a flexible catheter connected to a 1 ml
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syringe. Mice received 0.3 ml of either vehicle (25% ethanol,
control groups) or TNBS (inflammation groups) solution.
To assess the severity of induced colonic inflamma-
tion in vivo, the daily disease activity index (DAI) was
calculated by scoring changes in animal weight, occult
blood positivity, gross bleeding, and stool consistency
as previously described [16].
Histological and biochemical evaluation of inflammation
in vitro
Segments of the colon and the entire urinary bladder
were isolated from WT and TRPV1−/− mice at the end
of physiological experiments. One part of each tissue was
fixed in 4% paraformaldehyde for histological evaluation.
Fixed samples of the colon and urinary bladder were em-
bedded in paraffin and sectioned at 10 μm thickness. The
samples were stained with hematoxylin and eosin (H&E
staining kit, Richard-Allan Scientific, Kalamazoo, MI,
USA) and assessed for the signs of inflammation under a
light microscope. Another part of each specimen was
snap-frozen in liquid nitrogen and stored at −80°C for
running a myeloperoxidase (MPO) assay using MPO
ELISA kit (Alpco, Salem, NH, USA) as previously
described [16].
Surgical procedure to catheterize the urinary bladder for
cystometry
Mice included in the groups for urodynamic evaluation
of the urinary bladder function (awake cystometry)
underwent survival surgical procedure for catheter inser-
tion. An animal was anesthetized with isoflurane
(VEDCO, St. Joseph, MO, USA), and a polytetrafluoro-
ethylene catheter with a blunted end (Catamount
Research, St. Albans, VT, USA) was sutured in place at
the bladder dome and tunneled out the abdomen to the
nape of the neck where it was then inserted into the end
of a 22-gauge angiocath intravenous catheter. Upon
determination of the optimal length, the catheter was
affixed to the angiocath with super glue. The angiocath
was first tested with a gentle saline infusion to reveal no
leak at the bladder, then capped and the abdomen was
closed in layers. The angiocath was anchored to the
fascia and skin of the neck using two to three 3–0 Vicryl
sutures. After recovery from anesthesia, animals were
returned to the animal facility and kept in individual
cages to avoid possible damage to the catheters by their
cage mates. Mice were allowed to recover from surgery
for 4 days followed by cystometric evaluation of bladder
function under normal physiological conditions without
anesthesia (baseline cystometry). After initial urody-
namic evaluation, mice received a single intracolonic
instillation of either vehicle or TNBS, as described
above, followed by repeated cystometric evaluation at 3
to 5 days post-treatment.
Assessment of urodynamic parameters of bladder
function
Conscious mice were placed in cystometry cages (16 cm
width, 12 cm height, and 24 cm length) without any
restraint and allowed to acclimate for 30 min. The tip of
the exteriorized bladder catheter located at the base of
the mouse neck was connected to a pressure transducer
and an infusion pump of the cystometry station (Small
Animal Laboratory Cystometry, Catamount Research and
Development, St. Albans, VT, USA) using a T-shaped valve.
Room temperature saline solution (0.9% NaCl) was infused
in the bladder at a rate of 10 μl/min. Voided urine was
collected in the tray connected to a force displacement
transducer integrated into the data acquisition system.
Each animal was observed for up to six to eight voiding
cycles. Urodynamic values were recorded continuously
using data acquisition software (Small Animal Laboratory
Cystometry, Catamount Research and Development, St.
Albans, VT, USA). The following cystometric parameters
were recorded and analyzed in this study: bladder capacity,
pressure at the start of micturition, micturition rate, intra-
vesical pressure, inter-micturition interval, and the number
of non-micturition contractions. Non-micturition contrac-
tions were defined as increased values in detrusor pressure
from baseline that had amplitudes of at least a third of
maximal pressure at the start of micturition. Cystometric
parameters were uploaded from the acquisition software
into analysis software (SOF-552 Cystometry Data Analysis,
Version 1.4, Catamount Research and Development Inc.,
St. Albans, VT, USA) for statistical analysis.
In vitro measurements of detrusor contractility
For in vitro recordings of detrusor contractility, animals
were euthanized with overdose of sodium pentobarbital
(150 mg/kg). Midline laparotomy was performed to remove
the urinary bladder, which was divided in two halves longi-
tudinally and weighed. Full-thickness strips of the bladder
wall were tied to silk threads and suspended from L-shaped
hooks in 15-ml organ bath chambers. The chambers were
filled with the Tyrode buffer (in mM: 125 NaCl, 2.7 KCl,
23.8 NaHCO3, 0.5 MgCl2·6H2O, 0.4 NaH2PO4·H2O, 1.8
CaCl2, and 5.5 dextrose), maintained at 37°C, and perfused
continuously with a mixture of 95% O2 and 5% CO2. After
a 30-min equilibration period, the length of optimal force
development (L0) was determined by increasing the length
of each strip in 1.5-mm increments until maximal contract-
ile response to electrical field stimulation (EFS; 70 V, 32 Hz,
train duration of 1 ms) was achieved. The tissues were
washed three times with Tyrode buffer (10 min each) to re-
equilibrate the muscle. Depolarization with high-potassium
chloride solution (KCl, 125 mM) was carried out next to
evaluate the tonic and phasic properties of the detrusor
muscle. The tissues were washed three times (10 min each)
with Tyrode buffer before the application of additional
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drugs. One strip from each bladder was stimulated with
muscarinic receptor agonist carbachol (CCh) whereas the
second strip underwent stimulation with a protein kinase
C (PKC) activator followed by a Rho kinase (ROK) inhibi-
tor. Cumulative doses of CCh (10−7 to 10−4 M) were used
to trigger muscle contractions and assess the contractile
response to muscarinic receptor activation. Phorbol-12,13-
dibiturate (PDBU, 1 μM) was used as a PKC activator
followed by application of Y27632 (20 μM), a ROK inhibi-
tor. Additional groups of mice (WT and TRPV1−/−) were
used to evaluate the effects of ROK inhibitor on detrusor
contractility induced by KCl. Contraction parameters were
measured using PowerLab Lab-Chart version 7.1.2 software
(ADinstruments, Colorado Springs, CO, USA). The raw
traces were analyzed manually and then exported
into SigmaPlot 11 Software (Systat Software, San Jose,
CA, USA).
Surgical procedure for labeling urinary bladder
sensory neurons
Mice were anesthetized with 2% isoflurane and held on
a warming pad inside the designated hood to minimize
an investigator`s exposure to the anesthetic. A midline
laparotomy was performed under the sterile conditions
to gain access to the pelvic organs. The distal colon was
exposed and DiI (1,1'-dioctadecyl-3,3,3'3'-tetramethylin-
docarbocyanine perchlorate; Molecular Probes, Eugene,
OR, USA; 1.5% w/v in methanol) was injected into the
colonic wall using a Hamilton syringe with 26 gauge
needle at six to ten sites. The colon was placed back into
the abdominal cavity and the urinary bladder was
exposed for injections. Fast Blue (Polysciences Inc.,
Warrington, PA, USA; 1.5% w/v in water) was injected
into the urinary bladder wall (detrusor) using the same
approach as described for the colon. We intentionally
performed double labeling to exclude cells receiving dual
afferent input from the distal colon and urinary bladder
as these convergent neurons would be directly affected
by colonic treatments [13]. The total volume of dye
injected into each organ was 20 to 25 μl. Adjacent pelvic
organs were isolated with gauze to soak up any spills
and prevent the labeling of adjacent structures during
dye injections. Additionally, the needle was kept in place
for 30 s after each injection. Any leaked dye was
removed with a cotton swab before placing the organ
into the pelvic cavity. Incisions were sutured in layers
under the sterile conditions followed by subcutaneous
injection of buprenorphine (0.5 mg/kg). Animals were
allowed to recover on a warm blanket until they gained
full consciousness and then were returned to their cages.
Mice underwent subsequent treatments with either
vehicle or TNBS 7 to 10 days after the labeling of dorsal
root ganglion (DRG) neurons.
Isolation of single sensory neurons for patch-clamp
experiments
Dorsal root ganglia were dissected and removed bilaterally
at L6-S2 levels. Tissues were treated with collagenase
(Worthington, type 2, Biochemical Corp., Lakewood, NJ,
USA) in F-12 medium (Invitrogen, Carlsbad, CA, USA)
for 90 min in an incubator with 95% O2 and 5% CO2 at
37°C. Isolated ganglia were then rinsed in phosphate-
buffered saline and incubated for 15 min in the presence
of trypsin (Sigma-Aldrich, St. Louis, MO, USA; 1 mg/ml)
at room temperature. The enzymatic reaction was termi-
nated in Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% of fetal bovine serum. Single neurons
were obtained by gentle trituration using fire-polished
Pasteur pipettes in DMEM with trypsin inhibitor (2 mg/ml;
Sigma-Aldrich, St. Louis, MO, USA) and deoxyribonuclease
(DNase 1 mg/ml; Sigma-Aldrich, St. Louis, MO, USA). The
cell suspension was centrifuged for 10 mins at 700
rpm (4°C), and supernatant was discarded. The pellet,
containing sensory neurons, was resuspended in 2 ml
of DMEM containing 10% of fetal bovine serum. Neurons
were plated on poly-L-ornithine-coated 35 mm Petri dishes.
Isolated cells were maintained overnight in an incuba-
tor at 37°C with 95% O2/5% CO2 and were used for
electrophysiological experiments within 24 hours.
Electrophysiological recordings of voltage gated Na+
currents from bladder DRG neurons
Bladder-labeled neurons were identified using specific filter
for Fast Blue (UV-2A, Nikon, Tokyo, Japan) under an
inverted fluorescent microscope (Ti E2000-5, Nikon). Only
neurons exhibiting bright blue fluorescence (Fast Blue
labeled) were used for Na+ current recordings using perfo-
rated whole-cell patch clamp technique. Neurons with red
(colon projecting) and pink (convergent colon-bladder
neurons) fluorescence were excluded from the study. For
voltage clamp experiments the external solution contained
(in mM): NaCl 45, TEA Chloride 30, Choline Chloride 60,
KCl 5.4, MgCl2 1, CaCl2 1, HEPES 5, D-glucose 5.5,
adjusted with NaOH to pH 7.4. Pipette solution for these
experiments consisted of (in mM): L-aspartic acid 100,
CsCl 30, MgCl2 2, Na-ATP 5, EGTA 5, HEPES 5 adjusted
with CsOH to pH 7.2. CdCl (100 μM) was added to the
external solution in order to block voltage-gated calcium
currents. Freshly made Amphotericin B (0.24 mg/ml,
ACROS Organics, Morris Plains, NJ, USA) was added to
the pipette solution for perforated whole-cell recordings.
Microelectrodes were fabricated from borosilicate capillary
glass (Sutter Instruments, Novato, CA, USA) and had resis-
tances of 2 to 5 MΩ when filled with internal solution.
Recordings commenced 5 min after the establishment of
whole cell access. Series resistance was compensated ≥80 to
85%, and the calculated junction potential was around
5 mV. Cells were excluded from analysis if uncompensated
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series resistance resulted in a maximum voltage error >5
mV or if the seal or access resistance were unstable.
Recordings and analysis of kinetic parameters of voltage-
gated Na+ channels (VGSC) were performed using previ-
ously established protocols described in [16]. pCLAMP
software (Axon Instruments, Union City, CA, USA) was
used for data acquisition and analysis.
Gene expression of voltage gated Na+ channels in
lumbosacral DRG
A separate set of WT (N = 5) and TRPV1−/− mice (N = 5)
was used for RNA isolation and real-time PCR analysis of
gene expression of VGSC including Nav1.7, Nav1.8, and
Nav1.9 members. These channels were selected due to
their exclusive expression in sensory ganglia and estab-
lished participation in nociceptive signaling [26,27]. L6-S2
sensory ganglia were isolated bilaterally and snap-frozen in
liquid nitrogen. Total RNA was extracted using Trizol
reagent following the protocol from Invitrogen (Carlsbad,
CA, USA) as previously described [21]. First strand cDNA
was synthesized from 2 μg of the total RNA with 200 U of
the superscript III reverse transcriptase (Invitrogen,
number 18080–051) in the presence of 40 U RNaseOUT,
10 mM DTT, dNTP mix at 10 mM and 50 μM of Oligo
(dT)20. Real-time PCR was run on 7500 Fast Real Time
PCR system (Applied Biosystems, Foster City, CA, USA).
TaqMan Gene Expression Master Mix (4369016-PEC) and
TaqMan™ primer/probe kits were used for mouse Nav1.7
(Mm00450762-s1), Nav1.8 (Mm00501467-m1), and
Nav1.9 (Mm00449377-m1) channels (all from Applied Bio-
systems, Carlsbad, CA, USA). Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) gene served as an endogenous
control for the quantification of gene expression. The data
were analyzed using comparative Ct values as previously
described [21]. For example, the Ct value for each gene of
interest (Nav1.7, Nav1.8, or Nav1.9) in the control group
was subtracted from that of GAPDH (housekeeping gene)
to obtain the ΔCt value. The same subtraction was done in
all treated groups to obtain the ΔCt. To compare the
changes in the expression levels of Nav1.7, Nav1.8, and
Nav1.9 genes between control and experimental tissues,
these two ΔCt values were subtracted to obtain the ΔΔCt.
The fold change was measured as 2−ΔΔCt.
Assessment of abdominal sensitivity using von Frey
filaments
Inflammation in the pelvic viscera is associated with
enhanced abdominal sensitivity due to convergence of
visceral and somatic inputs in the CNS. This phenomenon
is known as viscerosomatic referred hyperalgesia and
could be measured by using mechanical stimulation with
von Frey filaments on the lower abdominal area [28]. In
order to follow the dynamic changes in pelvic sensitivity
of mice during the occurrence of experimental colitis, we
tested animals right before the TNBS instillation (day 0 or
baseline) followed by daily measurements until the peak
of colonic inflammation developed (3 days post-instilla-
tion). The same approach was applied to mice in the
groups with intracolonic vehicle treatments. Mice were
tested in individual Plexiglas chambers (6 × 10 × 12 cm)
with a stainless steel wire grid floor (acclimation period
was 30 min before testing). Frequency of withdrawal
responses was tested using five individual fibers with
forces of 0.04, 0.16, 0.4, 1, and 4 g (Stoelting, Kiel, WI,
USA). Each filament was applied for 1 to 2 s with an inter-
stimulus interval of 5 s for a total of 10 times, and the
hairs were tested in ascending order of force. All tests
were performed by the same person who was unaware of
the phenotype/treatment of animals. Stimulation was
confined to the lower abdominal area in the general vicin-
ity of the bladder, and care was taken to stimulate different
areas within this region to avoid desensitization or ‘wind-
up’ effects. Retraction of the abdomen, licking or scrat-
ching of the area of filament stimulation, and jumping-like
behavior were considered as positive responses to filament
stimulation as previously described [28].
Chemicals and drugs
All chemicals were obtained from Sigma-Aldrich with
the exception of DiI (Molecular Probes, Invitrogen, Eugene,
OR, USA) and Fast Blue (Polysciences, Warrington, PA,
USA). Isoflurane was purchased from VEDCO Inc.
(St. Joseph, MO, USA) and Amphotericin B from
ACROS (Organics, Morris Plains, NJ, USA). Trizol
kit for RNA/protein isolation and SuperScript III Reverse
Transcriptase were obtained from Invitrogen (Carlsbad,
CA, USA).
Statistical analysis
All data are expressed as the mean ± standard error of
the mean (SEM). N reflects the number of animals per
group and n corresponds to the number of samples in
each group. Statistical significance between the groups
was assessed by one-way repeated measures ANOVA
followed by Bonferroni`s post hoc test when appropriate
(Systat Software Inc., San Jose, CA, USA). Difference
between the groups and treatments was considered
statistically significant at P ≤0.05.
Results
Absence of TRPV1 receptors does not eliminate the
development of colonic inflammation
Severity of inflammatory reaction induced by TNBS in
WT and TRPV1−/− mice was assessed by histological and
biochemical methods as previously described [16,21].
Analysis of H&E-stained sections of the distal colon in
both WT (N = 10) and TRPV1−/− (N = 10) groups
revealed that intracolonic vehicle did not evoke any
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detectable structural changes in the colonic wall
(Figure 1A). However, TNBS treatment induced crypt
segmentation, local infiltration and thickening of the
muscle layer in the distal colon in both groups of
animals (Figure 1A). The cytoarchitecture of the
bladder wall was not affected by either treatment in
all tested animals (data not shown). The MPO assay
is a validated biochemical method of grading inflam-
mation in the tissue and measures the amount of
MPO enzyme released by neutrophils at the site of
inflammation [29]. The concentration of the enzyme
was increased 3-fold in the colon of both WT (N = 10)
and TRPV1−/− (N = 10) mice in TNBS groups (Figure 1B)
but was unchanged in the urinary bladder (Figure 1C).
Taken together, these data demonstrate substantial inflam-
matory changes in the distal colon during acute colitis in
both WTand TRPV1−/− groups suggesting that the lack of
TRPV1 receptors does not prevent the colon from the
development of acute inflammatory reaction.
Urodynamic analysis of bladder function in awake
unrestrained mice
To evaluate the effects of colon-bladder cross-sensitization
on the micturition parameters in vivo, we performed cysto-
metric assessment of bladder function during slow continu-
ous bladder filling in conscious mice. Cystometrograms
were recorded under control conditions in WT (N = 4) and
TRPV1−/− (N = 5) mice followed by second evaluation at 3
to 5 days post-TNBS. Figure 2 shows cystometric traces
obtained from a TRPV1−/− mouse before (A) and after
TNBS application (B). Urodynamic parameters were first
compared to the baseline to evaluate the effects of TNBS-
induced colitis on the voiding reflex in each animal fol-






















































Figure 1 Development of acute inflammation in the distal colon in WT and TRPV1−/− mice. (A) Hematoxylin and eosin (H&E) staining of
the distal colon in rats with intracolonic vehicle (Control) and 2,4,6-trinitrobenzene sulfonic acid (TNBS) treatment in wild-type (WT) and transient
receptor potential vanilloid 1 knockout (TRPV1−/−) mice (20X). In the groups with TNBS treatment please note the signs of colonic inflammation
and tissue damage including sites of hemorrhage, infiltration and disruption of the colonic crypts (c). (B) Concentration of myeloperoxidase
(MPO) enzyme in the distal colon in mice with and without active colonic inflammation. (C) MPO activity in the urinary bladder is unchanged by
experimental colitis. *P ≤0.05 to respective control.
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Analysis of cystometrograms in WT and TRPV1−/− mice at
baseline showed that the average intermicturition interval
was increased by 32.9% in KO animals in comparison to
WT littermates (P ≤0.05, Figure 2C). However, non-voiding
contractions were observed more frequently in TRPV1−/−
mice (3.1 ± 1.2 vs 1.1 ± 0.3 in WT group, P ≤0.05). Other
urodynamic characteristics were not different between WT
and KO animals.
Intracolonic TNBS had a profound effect on the function
of the urinary bladder in both WT (N = 4) and TRPV1−/−
(N = 5) groups. At 3 to 5 days after TNBS treatment, inter-
micturition interval was reduced from 638 ± 70.7 s to
393.3 ± 70.8 s in KO group (P ≤0.05 to vehicle) and from
480.3 ± 43.1 s to 265.9 ± 14.8 s in WT group (P ≤0.05 to
respective vehicle, Figure 2C). Likewise, bladder capacity
was reduced by 64% in WT mice and by 37% in TRPV1−/−
littermates during colitis (P ≤0.05 to vehicle, Figure 2D).
Occurrence of bladder dysfunction was also associated
with decreased voided volume in both groups of animals
(Figure 2E). In WT mice, the average voided volume per
cycle was reduced by 67% during active colitis, however, in
KO group, a decrease was only 36.4% (P ≤0.05 to vehicle,
Figure 2E). Taken together, these results suggest that the
effects of colitis-induced cross-sensitization on bladder
function were attenuated in TRPV1−/− mice.
Differential effects of experimental colitis on the
contractility of DSM in WT and TRPV1−/− mice
We performed a series of in vitro experiments using iso-

































































































Figure 2 Cystometric evaluation of bladder function before and after the development of a neurogenic bladder. (A-B) Representative
traces of the cystometrograms recorded in a freely moving transient receptor potential vanilloid 1 knockout (TRPV1−/−) mouse before (A) and
after (B) the induction of colonic inflammation. Arrows point to non-micturition contractions. (C) Comparison of the duration of intermicturition
interval (IMI) in wild-type (WT) and genetically modified mice. (D) Analysis of bladder capacity (BC) before and after 2,4,6-trinitrobenzene sulfonic
acid (TNBS) treatments. (E) Changes in the voided volume induced by experimental colitis. BP, bladder pressure. *P ≤0.05 to respective vehicle
group, #P ≤0.05 to WT group.
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gene knockout on the mechanisms of detrusor smooth
muscle (DSM) contractility. Isometric contractions in
response to EFS at 32 Hz were evaluated in muscle strips
isolated from WT and TRPV1−/− mice (Figure 3A). This
frequency was chosen based on our previous studies that
showed significant alterations in detrusor contractility at
higher frequencies during acute colonic inflammation
[14,22]. The maximal amplitude of the normalized con-
tractile response to EFS was 44.4 ± 10.8 g/g in WT group
under control conditions and increased 2-fold after TNBS
treatment (85.9 ± 12.3 g/g, P ≤0.05 to control, Figure 3B).
The contractility of DSM isolated from TRPV1−/− mice
reached 24.1 ± 4.5 g/g in the control group, which was
lower than in respective WT group (P = 0.11 to WT,
Figure 3B). However, colonic inflammation had similar
effect on the detrusor of TRPV1−/− animals causing 2-fold
increase in the contractile response (P ≤0.05 to vehicle,
Figure 3B).
Stimulation of DSM strips in vitro with KCl (Figure 3C)
allowed evaluation of the effects of TRPV1 gene knockout
on DSM contractility due to depolarizing effect of KCl on
smooth muscle cells [30]. The normalized amplitude of
the contractile response to KCl was 22.7 ± 3.3 g/g in
TRPV1−/− group, which was lower than in WT group
(44.5 ± 12.2 g/g), however, this difference did not reach
statistical significance (P = 0.12 to WT, Figure 3D).
Intracolonic treatment with TNBS had no effect on
KCl-induced contractility of the detrusor in WT
animals but caused a significant up-regulation of the
response in TRPV1−/− strips (P ≤0.05 to respective
control, Figure 3D).
We further investigated the effects of TRPV1 gene
knockout on cholinergic regulation of DSM by studying
the concentration-contractility response relationship upon
application of carbachol (CCh). Cumulative addition of































































Figure 3 Contractility of the detrusor muscle isolated from WT and TRPV1 KO mice. (A) Representative raw tracers of the detrusor
contractile responses to electric field stimulation (EFS) in wild-type (WT) and transient receptor potential vanilloid 1 knockout (TRPV1−/−) mice.
(B) Normalized contractile response of isolated detrusor smooth muscle (DSM) strips in response to electric field stimulation (EFS, 32 Hz).
(C) Representative raw tracers of the detrusor muscle responses to KCl stimulation in WT and TRPV1−/− mice. (D) Changes in the peak amplitude
of the detrusor muscle contractions upon stimulation with 125 mM of potassium chloride (KCl). All results are presented as mean ± SEM. Star
symbol marks the statistical significance between the groups.
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concentration-dependent contractions in vehicle-treated
WT animals (Figure 4A). Acute colonic inflammation
diminished the response of the detrusor muscle to
stimulation with CCh in both WT and TRPV1−/−
groups, however, the difference did not reach statistical
significance (Figure 4B).
Comparison of PKC and ROK dependent contractions in
DSM upon colon-bladder cross-sensitization
Increased sensitivity of DSM to KCl stimulation induced
by colonic inflammation in TRPV1−/− mice suggested
potential modulation of the signaling changes in muscle
contractile apparatus. Therefore, we tested the effects of
PKC activator PDBU on detrusor contractility and Rho-
kinase inhibitor Y27632 on relaxation of PDBU-induced
contractile response in DSM isolated from WT and
TRPV1−/− mice (Figure 5A). The normalized amplitude
of contractile response to PDBU was 6.5 ± 1.8 g/g in
WT group (n = 6) and 3.2 ± 1.1 g/g in TRPV1−/− strips
(n = 8, P >0.05, Figure 5B). Colonic inflammation
increased responses to PKC activator by 110% in WT
group and by 133% in TRPV1−/− group (P ≤0.05 to respec-
tive baseline, Figure 5B). Maximal contractile response to
PDBU was taken as 100% before the application of Rho-
kinase inhibitor Y27632. Application of Y27632 caused
relaxation of DSM in vehicle-treated WT mice by 76%,
whereas the effect on the strips from KO animals was
around 40% (Figure 5C). Colonic inflammation significantly
reduced the relaxation of DSM strips in WT group but had
no effect in TRPV1−/− mice (Figure 5C).
To further clarify the role of ROK pathway in the
response of isolated detrusor to KCl stimulation, we per-
formed an additional series of experiments using four
groups of WT and TRPV1−/− mice with and without
colonic inflammation (N = 4, n = 8 in each group). Experi-
mental design included initial stimulation of detrusor strips
with KCl followed by wash and subsequent incubation with
Rho-kinase inhibitor Y27632 for 30 min. After incubation
with the drug, the contractile response of the same strips to
KCl was tested again. The normalized amplitude of the ini-
tial contractile response to KCl in all tested groups was













































Figure 4 Muscarinic receptor-dependent regulation of DSM contractions. (A) Representative raw traces of detrusor contractions in response
to 0.1 to 100 μM of carbachol (CCh) in wild-type (WT) and transient receptor potential vanilloid 1 knockout (TRPV1−/−) mice. (B) Concentration-
dependent contractile responses of the detrusor muscle upon CCh stimulation.
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with Y27632 compound did not significantly affect the
amplitude of KCl-induced contractions in either group
(Figure 5D) suggesting that the ROK-dependent compo-
nent of the detrusor response to KCl was not directly
affected by the knockout of TRPV1 gene.
Colonic inflammation up-regulates voltage-gated sodium
channels in bladder sensory neurons from WT but not
TRPV1−/− mice
In the next set of experiments we aimed to determine if
knockdown of TRPV1 gene would affect excitability of
bladder sensory neurons via effects on voltage-gated so-
dium channels (VGSC) as we previously reported for a
rat model of cross-sensitization [16,31]. Retrograde la-
beling of lumbosacral sensory neurons revealed three
populations of isolated DRG neurons: colon-projecting,
bladder-projecting and colon-bladder convergent neu-
rons as previously detected [13,15]. We intentionally
performed double labeling to exclude from the experi-
ments neurons receiving dual afferent input from the
distal colon and urinary bladder as these neurons would
be directly affected by colonic treatments. The number
of double labeled cells was around 10% as previously
reported [13,15]. Only neurons labeled with Fast Blue
(bladder projecting) underwent electrophysiological
evaluation and were used for data analysis.
The current–voltage (I-V) relationship of total Na+
current recorded upon membrane depolarization in bladder
afferent neurons from WT mice is shown in Figure 6A.
Acute colonic inflammation increased the peak amplitude
of total Na+ current by 2-fold from −153.4 ± 17.4 pA/pF
at −20 mV in the control group (N = 6, n = 9) to −256.5 ±
24.1 pA/pF in the acute colitis group (N = 5, n = 7, P ≤0.05,
Figure 6A). The amplitude of total Na+ current recorded in
bladder DRG neurons from TRPV1−/− mice (N = 6, n = 8)













































































Figure 5 Differential effects of colonic inflammation on PKC and ROK signaling in the bladder smooth muscle in mice lacking TRPV1
receptors. (A) Representative raw tracers of the detrusor contractile responses to protein kinase C (PKC) activator (phorbol-12,13-dibiturate
(PDBU), 1 μM) in wild-type (WT) and transient receptor potential vanilloid 1 knockout (TRPV1−/−) mice. (B) Normalized contractile response of
isolated detrusor smooth muscle (DSM) strips in response to PDBU in WT and TRPV1 KO mice. (C) DSM relaxation response upon application of
Rho-kinase (ROK) inhibitor Y27632 (20 μM) after PDBU-induced contractions. The maximal amplitude of contraction induced by PDBU was taken
as 100%. Star symbols mark the statistical significance between control and treatment groups whereas pound symbols reflect significant
difference between WT and KO mice. (D) Normalized contractile response of detrusor muscle contractions upon stimulation with high potassium
chloride (KCl, 125 mM) after 30 min incubation of muscle strips with ROK inhibitor Y27632 (N = 4, n = 8 in all groups).
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respective WT group (N = 5, n = 7), however, intracolonic
TNBS had no effect on Na+ current in KO animals
(Figure 6B).
We next assessed the kinetic parameters of Na+ currents
after the induction of experimental colitis. The steady-state
activation was studied by using a three-pulse protocol with
a negative pre-pulse to −110 mV and a series of short
pulses (10 ms duration) to activate Na+ currents as previ-
ously described [16]. The amplitude of steady-state activa-
tion was measured at the peak of tail current upon the
voltage step to −70 mV, normalized and plotted as I/Imax
against the voltage. The amplitude of steady-state in-
activation was measured at a series of membrane de-
polarizing steps ranging from −100 mV to +70 mV.
In the group of WT mice, neither rate of activation,
nor steady-state inactivation kinetics of total Na+ current
in bladder sensory neurons were affected by acute colitis
(Figure 6C). However, in TRPV1−/− neurons, acute
colitis induced a rightward shift in steady-state inacti-
vation by 7 mV (V1/2 = −39.7 ± 1.9 mV in the vehicle
group vs −32.7 ± 1.7 mV in TNBS group, P ≤0.05,
Figure 6D).
Up-regulation of gene expression of VGSC in lumbosacral
DRG by colitis is attenuated in TRPV1 KO mice
To correlate the observed functional changes of the
recorded VGSC in TRPV1−/− mice with potential effects
on gene expression of VGSC in sensory neurons involved
in nociceptive signaling, we performed quantitative RT-
PCR analysis. This set of experiments was carried out on
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Figure 6 Effects of TRPV1 gene knockout on function of voltage-gated Na+ currents recorded in bladder sensory neurons. (A) Current–
voltage (I-V) relationship of total Na+ current recorded in bladder dorsal root ganglia (DRG) neurons after intracolonic 2,4,6-trinitrobenzene
sulfonic acid (TNBS) treatment in wild-type (WT) mice. *P ≤0.05 when compared to vehicle group. (B) Current–voltage (I-V) relationship of total
Na+ current recorded in bladder sensory neurons isolated from transient receptor potential vanilloid 1 knockout (TRPV−/−) animals. (C) Voltage
dependence of steady-state activation and inactivation of total Na+ current recorded in bladder DRG neurons from WT mice. The steady-state
activation of voltage-gated sodium channels (VGSC) was assessed by a three-pulse protocol with a negative pre-pulse to −110 mV and a series of
short pulses of 10 ms duration from −110 mV to +70 mV to activate Na+ currents. The amplitude of steady-state inactivation was measured at 0
mV after 150 ms depolarizing pulses ranging from −100 mV to 70 mV. (D) Activation and inactivation kinetics of total Na+ current recorded in
lumbosacral bladder neurons isolated from TRPV1 KO mice.
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the whole L6-S2 ganglia due to the presence of a limited
number of retrogradely labeled bladder neurons. The
DRG from both vehicle and TNBS groups were harvested
3 days post-treatment. The comparison of mRNA levels of
VGSC between WT (N = 4) and TRPV1−/− (N = 4) mice
did not reveal significant differences under control physio-
logical conditions (data not shown). mRNA expression of
VGSC in L6-S2 DRG isolated from WT mice showed 3-
fold up-regulation for Nav1.7 channel and 2-fold increase
for Nav1.8 channel by experimental colitis (N = 5, P ≤0.05
to respective vehicle, Figure 7A). The Nav1.9 mRNA level
was also increased in WT group, but did not reach the
level of statistical significance. The effects of colonic
inflammation on gene expression of Nav1.7, Nav1.8 and
Nav1.9 channels were diminished in TRPV1−/− ganglia
showing 2-fold up-regulation for Nav1.7 channel only
(N = 5, P ≤0.05 to vehicle, Figure 7B).
Lack of TRPV1 receptors delays the development of
abdominal hypersensitivity during colon-bladder
cross-talk
Abdominal sensitivity was daily tested in WT and
TRPV1−/− mice at the baseline and after intracolonic
treatments with either vehicle or TNBS. Figure 8 sum-
marizes the frequency of responses in the lower abdo-
minal area in all tested mice. Mechanical stimulation of
the pelvic area under control conditions (vehicle treat-
ment) in both WT (N = 4, Figure 8A) and TRPV1−/−
mice (N = 4, Figure 8C) resulted in a response frequency
that correlated with the applied force, reaching around
20% at the maximal tested force of 4 g during the entire
tested period . In the group with TNBS treatment, WT
mice showed increased sensitivity to the filament testing
and responses reached 40% at applied forces of 1 and 4
g (Figure 8B, N = 5, P ≤0.05 to baseline). An increase in
pelvic sensitivity became most significant at 3 days after
the treatment with statistically higher percentage of
responses at all tested forces (Figure 8B, N = 6, P ≤0.05
to baseline). Mice in TRPV1−/− group with had similar
baseline sensitivity to von Frey filaments when compared
to WT group. TNBS application did not evoke signifi-
cant changes in withdrawal response 1 day after the
treatment but increased abdominal sensitivity at days 2
and 3 up to 40% and 65%, respectively, for 4 g filaments
(P ≤0.05 to vehicle, Figure 8D). These results provide
evidence that colonic inflammation leads to an increased
viscerosomatic response associated with abdominal
hyperalgesia and discomfort, and the lack of TRPV1
receptors delays the development of viscerosomatic
hyperalgesia in KO mice.
Discussion
This is the first report which evaluated viscero-visceral
cross-reflexes in TRPV1 KO mice and confirmed previ-
ously reported data that transient inflammation of the distal
colon triggers the development of neurogenic bladder dys-
function via TRPV1-related pathways [14,16,18,19,21,32].
Our results provide direct evidence that the lack of TRPV1
receptors does not prevent the occurrence of colon-bladder
cross-sensitization induced by transient colitis, however,
several important physiological characteristics of bladder
function are altered by the knockout of TRPV1 gene. The
major differences included prolonged intermicturition
interval in KO animals followed by reduced urodynamic
responses during active colitis; up-regulation of DSM con-
tractility in response to KCl in TRPV1−/− mice with
inflamed colon; diminished relaxation of DSM in transgenic
animals in the presence of ROK inhibitor; attenuated effects
of colonic inflammation on expression and function of
VGSC in bladder sensory neurons from TRPV1−/− mice;








































Figure 7 Gene expression of voltage-gated sodium channels Nav1.7, Nav1.8 and Nav1.9 in L6-S2 dorsal root ganglia. (A) Bar chart
shows the mRNA level changes of voltage-gated sodium channels (VGSC) in lumbosacral dorsal root ganglia (DRG) of wild-type mice with and
without neurogenic bladder dysfunction induced by colonic inflammation. (B) mRNA levels for Nav1.7, Nav1.8 and Nav1.9 in L6-S2 DRG isolated
from transient receptor potential vanilloid 1 knockout (TRPV1−/−) mice. A star symbol reflects statistical significance between control and
treatment groups (P ≤0.05).
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upon colon-bladder cross-talk in genetically modified
animals.
An increasing number of clinical reports support animal
studies that peripheral and central cross-sensitization may
underlie unknown etiology of functional gastrointestinal
and urologic disorders associated with abdominal discom-
fort, visceral hypersensitivity, and chronic pelvic pain
[3,4,33]. While it is understood that animal models cannot
fully mimic human co-morbid conditions, they provide
valuable insight to study the underlying mechanisms. In
the present study, we established that the absence of
TRPV1 did not affect the severity of TNBS-induced colitis
in transgenic mice. Several previous reports presented
contradictory results on the role of TRPV1 in inflamma-
tion suggesting that the impact of TRPV1 involvement is
model-, dose-, and species-dependent [34]. For instance,
Okayama et al. [35] established that desensitization of
TRPV1 receptors with potent agonists elevated histo-
logical changes in the colon in dextran sulfate sodium
(DSS) model of colitis, whereas other groups demon-
strated a diminished level of the developed inflammatory
reaction in the distal colon of rats [21,36-38]. Experiments
on TRPV1 KO mice using a single dose of dinitrobenzene
sulfonic acid reported an increased susceptibility of the
colon to the applied inflammatory agent [39], however,
the effects of DDS on TRPV1 KO mice were clearly dose-
dependent. In 2% DSS-treated group, the lack of TRPV1
receptors decreased the severity of the induced colitis,
however, this difference was not observed for 5% DSS,
when much severe inflammatory reaction developed [40].
While the severity of inflammatory response could be
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Figure 8 Differences in visceral sensitivity between WT and TRPV1 KO mice in response to mechanical stimulation of the lower
abdominal region. (A) Abdominal responses to Von Frey filaments in wild-type (WT) mice with vehicle instillations (N = 4). (B) Responses to
pelvic stimulation in WT mice before and after intracolonic treatment with 2,4,6-trinitrobenzene sulfonic acid (TNBS) (N = 5). (C) Time course of
the responses to mechanical stimulation of the lower pelvic area in transient receptor potential vanilloid 1 knockout (TRPV1 KO) mice before and
after intracolonic instillations of the vehicle (N = 4). (D) Summary of the responses to pelvic stimulation recorded in TRPV−/− male mice during
experimental colitis (N = 6). Presented data are mean percentages of response frequency (± SE) before (baseline) and at days 1, 2, and 3 post-
treatment. ANOVA indicated a significant increase in response frequency in WT mice within 3 days post-TNBS treatment, whereas in KO mice the
difference reached statistical significance only at days 2 and 3 after the induction of colonic inflammation.
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possible that nerve fibers sensitive to capsaicin can be
activated by non-TRPV1-dependent pathways during
pathological conditions [40]. In a model of cutaneous
inflammation, the lack of TRPV1 receptors did not alter
the leukocyte accumulation suggesting participation of
both neurogenic and non-neurogenic mechanisms [41].
Importantly, the activation of sensory nerves was still
observed in TRPV1 KO mice providing evidence that
neurogenic inflammation may also develop via TRPV1
independent pathways [41].
Our analysis of urodynamic parameters in awake mice
confirmed previously reported involvement of TRPV1 in
regulation of urinary bladder function under both normal
and pathophysiological conditions. The intermicturition
interval in TRPV1−/− mice was increased along with the
number of non-voiding contractions at the baseline, and
the effects of experimental colitis on bladder capacity and
voided volume were diminished in comparison to WT
littermates. Our results are in line with the previous studies
which reported increased bladder capacity and non-
micturition contractions [42] as well as attenuated bladder
distension-induced afferent discharge in TRPV1−/− mice
[43]. Participation of TRPV1 in bladder sensitivity and pain
was also demonstrated in several animal models of direct
bladder inflammation [44-46]. These combined results sug-
gest that TRPV1 pathways are involved in inflammatory
and neurogenic bladder dysfunctions, and also contribute
to the development of pelvic organ cross-sensitization.
Previous studies from our [14,16,20] and other
[12,15,17] laboratories established that colon-bladder
cross-sensitization develops predominantly, but not
exclusively, via neural pathways. It is well established
that TRPV1 channels are expressed not only on sen-
sory neurons but also on peripheral afferents supplying
visceral organs of the gastrointestinal and genitourinary
tracts [24,25,47]. Our data from isolated DSM strips clearly
demonstrate that the absence of TRPV1 expression on
bladder afferents did not cause significant changes in con-
tractile responses of the detrusor upon normal physio-
logical conditions. However, some modulatory changes in
the signaling cascades became more evident during add-
itional stimulation like active colonic inflammation or PKC
activation. Specifically, we found that the contractile
response of DSM to KCl stimulation was enhanced by
experimental colitis in KO animals. KCl is used as a tool to
bypass G protein-coupled receptor stimulation and activate
smooth muscle by changing potassium equilibrium poten-
tial and triggering membrane depolarization (reviewed in
[30]). Activation of TRPV1, a cation channel permeable
mostly to Ca2+, has the same depolarizing effect on the cell
but the major mechanism includes massive influx of Ca2+
through the pore of the channel [48]. Recent studies estab-
lished that activation of TRPV1 by capsaicin, a potent
TRPV1 agonist, is associated with PKC activation [49,50],
and the opening of TRPV1 channels is promoted by
channel phosphorylation [51]. PKC modulation of
TRPV1 channel function was previously shown to occur
under conditions of chronic pain resulting from nerve
damage or inflammation [50].
Rho kinase (ROK) pathway in bladder detrusor smooth
muscle was shown to be involved in the contractile
response of the isolated DSM to KCl [30]. ROK pathway is
critical for the maintenance of basal tone in DSM and
serves as a common final pathway of various contractile
stimuli in many species [52]. ROK directly phosphorylates
and inactivates myosin light chain (MLC) phosphatase,
ultimately increasing the phosphorylation state of myosin
and facilitating contraction [53]. Y27632, a ROK inhibitor,
was shown to reduce KCl-induced contractile force without
inhibition of KCl-induced increases in intracellular
Ca2+ [54-57], but with concomitant inhibition of MLC
phosphorylation [55,56].
The relationship between TRPV1 and ROK in the
detrusor muscle is currently not established, but activation
of TRPV1 resulted in inhibition of ROK in vascular
smooth muscle [58]. Fujimoto et al. previously investi-
gated the effects of capsaicin-induced relaxation on KCl-
induced contractions and phosphorylation of MLC in ileal
smooth muscle of rats [59]. They established that capsa-
icin relaxed intestinal smooth muscle after KCl-induced
contraction and this effect was accompanied by a decrease
in MLC20 phosphorylation [59]. To clarify the effects of
ROK inhibition on KCl-induced contractility of the DSM
in our setting, we performed a series of experiments
where DSM was tested with KCl after 30-min incubation
with a ROK inhibitor. Our results suggest that without
preliminary stimulation with PKC activator PDBU (as we
did in the primary set of experiments), the effects of ROK
inhibition on the contractility of the detrusor induced by
KCl were insignificant between the WT and TRPV1−/−
groups (Figure 5D). This data confirms the absence of the
direct effect of TRPV1 knockdown on detrusor muscle
contractile apparatus. However, the modulatory effects of
PKC and ROK pathways could be associated with indirect
mechanisms such as the altered release of sensory neuro-
peptides from TRPV1 fibers triggered by colonic inflam-
mation. TRPV1-expressing afferent nerves are well known
for their ‘efferent’ function associated with the release of
neuropeptides, mainly tachykinins and calcitonin gene-
related peptide (CGRP) upon peripheral stimulation [60].
It is possible that the absence of TRPV1 expression on af-
ferent nerves in TRPV1−/− mice can modulate tachykinin
levels in the detrusor which, in turn, are capable of sup-
pressing endogenous proteases like ROK [61]. Further
studies are warranted to evaluate the relationship between
detrusor contractility, expression of TRPV1 channels on
bladder afferents and release of sensory neuropeptides in
colon-bladder cross-talk.
Lei et al. Journal of Neuroinflammation 2013, 10:3 Page 14 of 18
http://www.jneuroinflammation.com/content/10/1/3
Sensory neurons receiving afferent input from the pelvic
viscera play a key role in the development of peripheral
cross-sensitization [13,15]. They express several types of
ion channels including TRPV1 and VGSC, which are well-
known transducers of nociceptive processing in pain path-
ways [26,27,48]. Excitability of sensory afferents is defined
by expression and function of VGSC [26,27]. Single cell
analysis of Na+ channel transcripts indicated that sensory
neurons innervating the pelvic viscera express a combin-
ation of tetrodotoxin-sensitive and -resistant Na+ channels,
which consist mostly of Nav1.6, Nav1.7, Nav1.8 and Nav1.9
members [62]. In this study, the peak amplitude of total
sodium current in neurons from vehicle-treated TRPV1−/−
mice was greater than that of neurons from the vehicle-
treated WT mice. Multiple sodium channel isoforms
are expressed in DRG neurons and play a central role
in neuronal electrogenesis. However, a number of
other ion channels also confer electrical excitability of
neurons including voltage-gated calcium and potassium
channels. Interactions between different ion channels and
co-expressed molecules lead to the occurrence of multiple
ionic conductances, which shape the cells' firing patterns,
and confirm that regulation of neuronal excitability is
a complex process. Under non-pathological conditions,
the firing properties of DRG neurons are usually main-
tained within a circumscribed range. This is a result of
homeostatic regulation of ion channel expression, post-
translational modification, and/or interaction with binding
partners or modulators [63]. While variations in the level
of expression of any VGSC isoform present within DRG
neurons could affect their level of excitability, computa-
tional models have demonstrated that multiple, distinct
sets of membrane parameters can produce similar levels
of activity. For instance, it has been proposed that changes
in expression of channel ‘B' can compensate for changes
in expression of channel ‘A' to maintain excitability within
a particular range [64]. Indeed, it was demonstrated
that overexpression of Shal potassium channel gene
in somatogastric ganglion neurons caused a large increase
in potassium current but little change in the neuron's
firing properties due to a compensatory increase in
expression of a hyperpolarization-activated inward current
[65]. Likewise, in Purkinje neurons isolated from NaV1.6
−/−
mice, sodium current density was reduced, however, an
up-regulation of calcium channels maintained excitability
near its normal level [66]. Therefore, while we observed
enhanced amplitude of VGSC current in TRPV1−/−
neurons, we could not confirm that these neurons
were hyperexcitable in comparison to WT phenotype.
Additional extensive studies are warranted to perform
comprehensive evaluation of neuronal excitability in
genetically modified animals.
Studies utilizing animal models of acute and chronic in-
flammation in different parts of gastrointestinal [11,67,68]
and genitourinary [44,69] systems showed an increased
excitability of DRG neurons receiving direct input from
the inflamed organs. Previously published data from
our group also established that colonic inflammation
increased excitability of bladder DRG neurons via an up-
regulation of VGSC [16]. However, cross-channel interac-
tions between TRPV1 and VGSC at the membrane level
have not been fully investigated. Under in vitro conditions,
application of capsaicin usually leads to a significant block
of VGSC [70], but intraluminal application of TRPV1
agonists in vivo causes an up-regulation of VGSC on
the cell soma and is associated with increased excitability of
sensory neurons [16]. Additional in vitro studies revealed
that capsaicin-induced blockade of VGSC is concentration-
dependent [71]. It was also established that the block of
VGSC by low concentrations of capsaicin was reversed in
TRPV1−/− mice [71]. There are a few suggested mecha-
nisms underlying functional interconnection between
TRPV1 and VGSCs. Indirect pathways include intercros-
sing of TRPV1 and VGSC signaling pathways via modula-
tion of the same transcriptional/translational factors or
recruitment of second messengers (for example cAMP or
intracellular Ca2+). Direct pathways involve TRPV1-VGSC
interactions within a complex as it was proven for other
channels [72-74]. It is possible that genetic knockdown of
TRPV1 gene in sensory neurons could lead to compensa-
tory changes by up- or down-regulation of other ion chan-
nels. Since VGSCs are the main source of positive charge
influx into sensory neurons, they could have been affected
by TRPV1 gene knockout during development. The future
research steps should determine if one of the VGSCs
expressed in DRG has some sort of capsaicin receptor and
whether modulatory subunits of both channels are involved
in TRPV1-VGSC ‘cross-talk’.
Inflammation in the pelvic viscera is associated with
enhanced abdominal sensitivity due to convergence of vis-
ceral and somatic inputs in the nervous system. This
phenomenon is known as viscerosomatic referred hyper-
algesia and could be measured by using mechanical stimu-
lation with von Frey filaments on the lower abdominal area
[28]. The referred hyperalgesia is proportional to the inten-
sity of the spontaneous visceral pain-related behavior
expressed by the animals. Increased responses of the lower
abdominal wall to mechanical stimulation are reflective of
and correlate with pain and discomfort arising from
inflamed pelvic organs [75]. Our behavioral results estab-
lished that the development of abdominal hypersensitivity
induced by colitis upon mechanical stimulation of the lower
pelvic region was delayed in TRPV1−/− mice. This observa-
tion is in line with the previously published studies con-
firming participation of TRPV1 in the development of
abdominal hyperalgesia and inflammatory pain [76]. Wang
et al. determined that the lack of functional TRPV1 did not
eliminate histological evidence of bladder inflammation in
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either cyclophosphamide- or acrolein-induced models of
bladder inflammation [46]. This group also established that
abdominal hyper-reactivity and cutaneous allodynia were
abolished in TRPV1−/− mice. Likewise, selective TRPV1
antagonists attenuated mechanical allodynia and hyperalge-
sia in rat models of neuropathic pain [76-78]. However,
TRPV1−/− mice did not reveal a significantly altered pheno-
type in the partial sciatic nerve ligation model of neuro-
pathic pain [79]. The use of RNA interference technologies
further confirmed model- and species-associated differ-
ences in test results from genetically and functionally modi-
fied animals. Functional knockdown of TRPV1 using
shRNA showed diminished behavioral responses to intra-
plantar injection of capsaicin, enhanced paw withdrawal la-
tencies to heat, and diminished tactile hypersensitivity in an
injury-induced neuropathic pain model [80,81]. siRNA
treatment also diminished spontaneous visceral pain behav-
ior induced by capsaicin application to the rectum of mice
[77]. Interestingly, spinal nerve injured TRPV1 knockout
but not shRNA-treated animals developed mechanical allo-
dynia and hypersensitivity [80]. These results indicate that
neither the complete loss nor a profound reduction in
TRPV1 channels can completely eliminate the effects of
visceral or cutaneous noxious stimulation on behavioral
responses suggesting that TRPV1 is not the only player in
nociceptive signaling.
Conclusions
In summary, the results of our extensive study clarified
the role of TRPV1 in the development of colon-bladder
cross-sensitization and associated dysfunction in the
lower urinary tract. Knockout of TRPV1 gene changed
several important physiological characteristics of bladder
function including prolonged intermicturition interval
along with reduced urodynamic responses during active
colitis in genetically modified mice; up-regulation of
DSM contractility in response to KCl in TRPV1−/− mice
with inflamed colon; diminished relaxation of DSM in
transgenic animals in the presence of ROK inhibitor, and
attenuated effects of colonic inflammation on VGSC in
bladder sensory neurons. The mechanisms underlying
neurogenic bladder dysfunctions due to pelvic organ
cross-interactions require further studies to provide
valuable information for the development of new
pharmacological approaches and therapeutic strategies
for the treatment of co-morbid conditions characterized
by functional pelvic pain arising from gastrointestinal or
genitourinary systems.
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